Literature DB >> 10371278

Chlamydia pneumoniae as a triggering infection in reactive arthritis.

T Hannu1, M Puolakkainen, M Leirisalo-Repo.   

Abstract

OBJECTIVE: To determine the role of Chlamydia pneumoniae as a triggering infection in reactive arthritis (ReA).
METHODS: Sixty patients with acute arthritis were screened for the evidence of triggering infections. In all patients, bacterial stool cultures, culture of Chlamydia trachomatis in urethra/cervix, and/or bacterial serology were studied. Chlamydia pneumoniae antibodies were measured by specific microimmunofluorescence test.
RESULTS: Thirty-five of 60 patients fulfilled the diagnostic criteria for ReA. Thirty-one patients had microbial/serological evidence of preceding infection due to Salmonella, Yersinia, Campylobacter or Chlamydia trachomatis, or they had enteritis or urethritis prior to arthritis. Four additional patients had high antibody titre for C. pneumoniae. Three of these four patients had preceding lower respiratory symptoms, and were positive for HLA-B27. The clinical picture of C. pneumoniae-positive ReA patients was similar to that of ReA patients with other definite aetiology.
CONCLUSION: Chlamydia pneumoniae is a triggering factor in approximately 10% of patients with acute ReA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10371278     DOI: 10.1093/rheumatology/38.5.411

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  29 in total

Review 1.  How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted?

Authors:  D Taylor-Robinson; A Keat
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

Review 2.  Reactive arthritis or chronic infectious arthritis?

Authors:  J Sibilia; F-X Limbach
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

3.  Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; Maria L Tondella; Deborah F Talkington
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

Review 4.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 5.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

6.  Clinical presentations of chlamydial and non-chlamydial reactive arthritis.

Authors:  Ahmet Ozgül; Ismail Dede; Mehmet Ali Taskaynatan; Hakan Aydogan; Tunç Alp Kalyon
Journal:  Rheumatol Int       Date:  2006-01-24       Impact factor: 2.631

Review 7.  Campylobacter reactive arthritis: a systematic review.

Authors:  Janet E Pope; Adriana Krizova; Amit X Garg; Heather Thiessen-Philbrook; Janine M Ouimet
Journal:  Semin Arthritis Rheum       Date:  2007-03-13       Impact factor: 5.532

8.  Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis.

Authors:  C Fendler; S Laitko; H Sörensen; C Gripenberg-Lerche; A Groh; J Uksila; K Granfors; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

9.  Do infections trigger juvenile idiopathic arthritis?

Authors:  Mustafa Aslan; Ozgur Kasapcopur; Hatice Yasar; Erdal Polat; Suat Saribas; Huseyin Cakan; Ahmet Dirican; Müzeyyen Mamal Torun; Nil Arısoy; Bekir Kocazeybek
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

10.  The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.

Authors:  John D Carter; Herve C Gerard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Clin Rheumtol       Date:  2012-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.